Daniele Calistri
University of Pavia
146 Papers
932 Citations
Daniele Calistri is an academic researcher from University of Pavia. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 32, co-authored 132 publications.
Chat about Author
Papers
Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results
TL;DR: Although preclinical data suggest that a pharmacological treatment targeting the epigenetic machinery has relevant activity over the neoplastic phenotype of NSCLC cells, clinical results are disappointing, leading only to short periods of disease stabilization in NSCLCs patients, and evidence calls for a significant rethinking of strategies for an effective epigenetic therapy of NSCRC.
14
Carcinosarcoma of the prostate: case report with molecular and histological characterization:
Samanta Salvi,Valentina Casadio,Filippo Martignano,Giorgia Gurioli,Maria Maddalena Tumedei,Daniele Calistri,Roberta Gunelli,Matteo Costantini +7 more
TL;DR: The findings suggest that carcinosarcoma has specific molecular characteristics that could be indicative for early diagnosis and treatment selection.
14
Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence
Claudia Rengucci,Giulia De Maio,Andrea Casadei Gardini,Mattia Zucca,Emanuela Scarpi,Chiara Zingaretti,Giovanni Foschi,Maria Maddalena Tumedei,Chiara Molinari,Luca Saragoni,Maurizio Puccetti,Dino Amadori,Wainer Zoli,Daniele Calistri +13 more
TL;DR: Results from the methylation analysis suggest that a classification based on molecular parameters could help to define the mechanisms involved in carcinogenesis and prove an effective method for identifying patients at high risk of recurrence.
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
José Garcia-Pelaez,Rita Barbosa-Matos,Silvana Polo Lobo,Alexandre Simões Dias,Luzia Garrido,Sérgio Castedo,Sónia Sousa,Hugo Pinheiro,Liliana Sousa,Rita Monteiro,Joaquín J Maqueda,Susana Fernandes,Fátima Carneiro,Nádia Pinto,Carolina Lemos,Carla M. A. Pinto,Manuel R. Teixeira,Stefan Aretz,Svetlana Bajalica-Lagercrantz,Judith Balmaña,Ana Blatnik,Patrick R. Benusiglio,Maud Blanluet,Vincent Bours,Hilde Brems,Joan Brunet,Daniele Calistri,Gabriel Capellá,S. Carrera,Chrystelle Colas,Karin Dahan,Robin de Putter,Camille Desseignés,Elena Domínguez-Garrido,Conceição Egas,D. Gareth Evans,Damien Feret,Eleanor Fewings,Rebecca C. Fitzgerald,Florence Coulet,María García-Barcina,Maurizio Genuardi,Lisa Golmard,Karl Hackmann,Helen Hanson,Elke Holinski-Feder,Robert Hüneburg,Mateja Krajc,Kristina Lagerstedt-Robinson,Conxi Lázaro,Marjolijn J. L. Ligtenberg,Cristina Martínez-Bouzas,Sonia Merino,Geneviève Michils,Srdjan Novakovic,Ana Patiño-García,G. Nadia Ranzani,Evelin Schröck,Inês Rodrigues da Silva,Catarina Silveira,Jose Soto,Isabel Spier,Verena Steinke-Lange,Gianluca Tedaldi,Maria-Isabel Tejada,Emma R. Woodward,Marc Tischkowitz,Nicoline Hoogerbrugge,Carla Santos de Oliveira +68 more
TL;DR: A genotype–phenotype analysis in families carrying rare CDH1 variants, comparing cancer spectrum in carriers of pathogenic or likely pathogenic variants (PV/LPV; analysed jointly) or missense variants of unknown significance, and testing the performance of lobular breast cancer-expanded criteria forCDH1 testing found no evidence for a positive association with these phenotypes.
13
The current role of telomerase in the diagnosis of bladder cancer.
TL;DR: In this article, a PubMed search was performed using the text terms "bladder cancer", "diagnosis", and "telomerase", and the results showed that the quantitative Telomerase Repeat Amplification Protocol (TRAP) assay performed in voided urine is an important non-invasive tool for the diagnosis of bladder tumors.
13